# Observational Study of Botulinum Toxin Type A in Patients With Urinary Incontinence Associated With Overactive Bladder

> **NCT02673047** · — · COMPLETED · sponsor: **Allergan** · enrollment: 474 (actual)

## Conditions studied

- Urinary Bladder, Overactive
- Urinary Bladder, Neurogenic

## Interventions

- **BIOLOGICAL:** botulinum toxin Type A

## Key facts

- **NCT ID:** NCT02673047
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 474 (ACTUAL)
- **Last updated:** 2016-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02673047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02673047, "Observational Study of Botulinum Toxin Type A in Patients With Urinary Incontinence Associated With Overactive Bladder". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02673047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*